Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60,893,283
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
8,887,474
-
Shares change
-
-2,504
-
Total reported value, excl. options
-
$6,151,871
-
Value change
-
-$260,570
-
Put/Call ratio
-
0%
-
Number of buys
-
11
-
Number of sells
-
12
-
Price
-
$0.6932
Institutional Holders of Equillium, Inc. - Common Stock (EQ) as of Q2 2024
As of 30 Jun 2024 Equillium, Inc. - Common Stock (EQ) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,887,474 shares of stock of the company.
Largest 10 holders included Decheng Capital LLC, TAKEDA PHARMACEUTICAL CO LTD, VANGUARD GROUP INC, Cota Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ADAR1 Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, Callan Capital, LLC, and STATE STREET CORP.
This table shows 24 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.